OverallDMNo DMOR
(95% CI)
OverallDMNo DMOR (95% CI)
Categorical variables
Male†1034 (46.2%)288 (57.5%)746 (42.2%)2.0 (0.9 to 3.3)3561 (43.8%)1091 (50.1%)2470 (41.4%)1.4 (1.2 to 1.7)
Obese‡1542 (54.1%)527 (72.9%)1015 (43.4%)3.5 (1.8 to 6.7)3695 (46.4%)1253 (57.6%)2442 (42.1%)1.9 (1.7 to 2.1)
Family history of DM1647 (55.1%)586 (71.8%)1061 (49.0%)2.7 (1.0 to 6.7)1079 (10.8%)437 (16.4%)642 (8.7%)2.1 (1.8,2.4)
Reduced HDL §1528 (38.2%)461 (47.2%)1067 (34.9%)1.7 (0.8 to 3.4)5510 (69.6%)1453 (66.2%)3766 (65.8%)1.0 (0.9 to 1.2)
Elevated LDL¶302 (7.3%)76 (9.1%)226 (6.7%)4.1 (0.6 to 3.6)1091 (13.0%)427 (18.5%)664 (10.9%)1.9 (1.6 to 2.2)
Elevated triglycerides**1186 (34.1%)420 (42.0%)766 (31.3%)1.6 (0.7 to 3.4)2274 (28.3%)956 (43.2%)1318 (22.7%)2.6 (2.3 to 3.0)
Elevated LFT††1274 (24.7%)347 (22.5)927 (24.4)0.9 (0.5 to 1.6)2991 (36.7%)959 (44.1%)2032 (33.9%)1.5 (1.4 to 1.7)
History of smoking‡‡922 (30.7%)276 (43.6%)646 (26.2%)2.2 (1.0 to 5.0)1168 (14.3%)317 (14.2%)851 (14.3%)1.0 (0.8 to 1.2)
Alcohol consumption§§1134 (37.5%)263 (33.2%)871 (40.4%)0.7 (0.3 to 1.6)882 (10.9%)228 (10.5%)654 (11.1%)0.9 (0.8 to 1.1)
Hypertension¶¶942 (41.3%)411 (62.9%)531 (33.6%)3.3 (1.6 to 6.9)2322 (26.9%)913 (37.2%)1409 (23.0%)2.0 (1.7 to 2.2)
  • *Continuous variables have mean (SD). Differences are displayed as (mean for DM) – (mean for non-DM). Boldface entries indicate statistical significance at the 95% confidence level.

  • †Categorical variables have count and per cent. Associations are displayed as OR, [odds(DM)/[odds(no DM)]. Boldface entries indicate statistical significance at the 95% confidence level.

  • ‡Defined as body mass index ≥30 for CCHC and body mass index ≥25.0 for PURSE.

  • §Defined as HDL <40 for men and <50 for women.

  • ¶Defined as LDL >160 mg/dL.

  • **Defined as serum triglycerides>150 mg/dL.

  • ††Defined as ALT>40 or AST>40.

  • ‡‡Reported smoking, past or present.

  • §§Current alcohol consumption, at least occasionally.

  • ¶¶Defined as systolic blood pressure >130 or diastolic blood pressure >85 or taking antihypertensive medication.

  • ALT, alanine aminotransferase; AST, aspartate aminotransferase; HDL, high-density lipoprotein; HOMA-IR, homeostasis model of insulin resistance; LDL, low-density lipoprotein; LFT, liver function tests.